Shandong Fiberglass Group Co., Ltd (SHA:605006)
China · Delayed Price · Currency is CNY 8.23
+0.75 (10.03%)
Aug 14, 2025, 2:45 PM CST
Achilles Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -5 | -98.93 | 105.34 | 535.79 | 546.03 | 172.37 | Upgrade |
Depreciation & Amortization | 306.77 | 306.77 | 324.87 | 329.85 | 315.53 | 294.38 | Upgrade |
Other Amortization | 1.74 | 1.74 | 4.75 | 4.65 | 4.8 | 4.8 | Upgrade |
Loss (Gain) From Sale of Assets | -57.27 | -57.27 | -181.9 | -157.24 | 7.72 | -0.67 | Upgrade |
Asset Writedown & Restructuring Costs | 25.49 | 25.49 | 9.57 | 9.41 | 5.74 | 11.75 | Upgrade |
Loss (Gain) From Sale of Investments | -3.37 | -3.37 | -0.6 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | -1.74 | -1.74 | 1.17 | 7.48 | - | - | Upgrade |
Other Operating Activities | -82.86 | 150.45 | 67.9 | 82.96 | 108.31 | 140.99 | Upgrade |
Change in Accounts Receivable | -160.54 | -160.54 | -268.98 | -179.62 | -306.11 | -319.84 | Upgrade |
Change in Inventory | -275.11 | -275.11 | -61.44 | -95.92 | -14.1 | -7.71 | Upgrade |
Change in Accounts Payable | 297.11 | 297.11 | 562.06 | 90.3 | 106.17 | 138.91 | Upgrade |
Change in Other Net Operating Assets | 0.07 | 0.07 | 0.36 | - | - | - | Upgrade |
Operating Cash Flow | 22.6 | 161.98 | 547.18 | 652.7 | 787.93 | 450.49 | Upgrade |
Operating Cash Flow Growth | -95.49% | -70.40% | -16.17% | -17.16% | 74.91% | - | Upgrade |
Capital Expenditures | -758.28 | -841.2 | -772.87 | -367.9 | -226.83 | -291.15 | Upgrade |
Sale of Property, Plant & Equipment | 70.11 | 70.11 | 294.24 | 187.74 | 11.38 | 1.02 | Upgrade |
Investment in Securities | 280 | 180 | -180 | - | - | - | Upgrade |
Other Investing Activities | 3.63 | 3.97 | - | - | - | - | Upgrade |
Investing Cash Flow | -404.55 | -587.13 | -658.63 | -180.17 | -215.46 | -290.13 | Upgrade |
Long-Term Debt Issued | - | 1,351 | 1,243 | 685.17 | 1,769 | 2,290 | Upgrade |
Long-Term Debt Repaid | - | -988.61 | -623.64 | -1,206 | -1,858 | -2,391 | Upgrade |
Total Debt Repaid | -904.51 | -988.61 | -623.64 | -1,206 | -1,858 | -2,391 | Upgrade |
Net Debt Issued (Repaid) | 498.91 | 362.39 | 619.23 | -520.78 | -89.51 | -101.28 | Upgrade |
Issuance of Common Stock | - | - | 53.11 | - | - | 334.52 | Upgrade |
Common Dividends Paid | -69.51 | -66.55 | -192.85 | -82.91 | -149.47 | -160.93 | Upgrade |
Other Financing Activities | -125.04 | 63.19 | -294.23 | -35.28 | 79.81 | -61.16 | Upgrade |
Financing Cash Flow | 304.36 | 359.03 | 185.27 | -638.97 | -159.17 | 11.15 | Upgrade |
Foreign Exchange Rate Adjustments | 3.1 | 1.74 | 3.61 | 0.78 | -5.6 | -1.74 | Upgrade |
Net Cash Flow | -74.49 | -64.37 | 77.43 | -165.65 | 407.7 | 169.77 | Upgrade |
Free Cash Flow | -735.69 | -679.22 | -225.69 | 284.8 | 561.1 | 159.34 | Upgrade |
Free Cash Flow Growth | - | - | - | -49.24% | 252.15% | - | Upgrade |
Free Cash Flow Margin | -35.05% | -33.86% | -10.25% | 10.24% | 20.41% | 7.98% | Upgrade |
Free Cash Flow Per Share | -1.07 | -1.10 | -0.36 | 0.47 | 0.94 | 0.31 | Upgrade |
Cash Income Tax Paid | 47.41 | -43.27 | 25.03 | 127.3 | 155.27 | 65.94 | Upgrade |
Levered Free Cash Flow | -558.1 | -504.67 | 536.15 | 47.68 | 582.98 | 142.85 | Upgrade |
Unlevered Free Cash Flow | -517.85 | -466.74 | 572.76 | 94.5 | 649.04 | 230.77 | Upgrade |
Change in Working Capital | -161.17 | -161.17 | 216.08 | -160.2 | -200.2 | -173.14 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.